|1.||Kain, Kevin C: 5 articles (04/2007 - 01/2003)|
|2.||Looareesuwan, Sornchai: 3 articles (04/2007 - 03/2002)|
|3.||O'Neill, Paul M: 2 articles (05/2013 - 03/2012)|
|4.||Lalloo, David G: 2 articles (05/2013 - 02/2007)|
|5.||Fisher, Nicholas: 2 articles (05/2013 - 03/2012)|
|6.||Biagini, Giancarlo A: 2 articles (05/2013 - 03/2012)|
|7.||Ward, Stephen A: 2 articles (05/2013 - 03/2012)|
|8.||Patel, Samir N: 2 articles (04/2007 - 12/2005)|
|9.||Boggild, Andrea K: 2 articles (04/2007 - 02/2007)|
|10.||Krudsood, Srivicha: 2 articles (04/2007 - 03/2002)|
|1.||Falciparum Malaria (Plasmodium falciparum Malaria)
09/01/2005 - "To investigate the pharmacokinetics, safety and efficacy of the recommended 3-day treatment regimen of Malarone in third-trimester pregnant women with acute uncomplicated falciparum malaria. "
01/01/2002 - "Based on our experience, Malarone appears to be effective, well-tolerated, and suitable for routine management of uncomplicated imported Plasmodium falciparum malaria."
09/01/2005 - "Malarone appeared to be effective and well tolerated when used for the treatment of falciparum malaria in pregnant women. "
02/01/2004 - "CV8 and Malarone are effective combinations against multi-drug resistant falciparum malaria. "
01/01/2002 - "The purpose of this open non-comparative retrospective study was to evaluate the efficacy and tolerance of Malarone for management of uncomplicated imported Plasmodium falciparum malaria. "
07/01/2004 - "Malarone appears to be an effective, safe and acceptable oral treatment for uncomplicated malaria."
09/01/2006 - "The protective efficacy of Malarone for all malaria and for P. "
04/01/1999 - "Malarone is a safe and effective new agent for treatment of malaria."
03/01/2007 - "The aim of the study was to estimate the effectiveness of Malarone in treatment and prophylaxis for the travelers to Thai-Myanmar border where multi-drug resistant malaria is highly endemic. "
09/01/2006 - "Malarone was compared with placebo in a double-blind, randomized, placebo-controlled trial of prophylaxis of malaria in predominately Plasmodium vivax areas of Colombia. "
10/01/2009 - "We also used an opportunity to test the efficacy of the antimalarial drug Malarone in treatment of the experimental infection. "
09/01/2014 - "The efficacy of Malarone(®) alone and in combination with doxycycline (DOXY) against Babesia gibsoni infections was examined in 8 dogs. "
03/01/2010 - "We used the anti-malarial drug Malarone to test experimentally for fitness effects of chronic malaria infection in a wild population of breeding blue tits (Cyanistes caeruleus). "
07/01/2001 - "Atovaquone-proguanil (Malarone) is a new antimalarial agent that is licensed in 35 countries as treatment against blood-stage infection, but its components (atovaquone and proguanil) have separately been shown to be active also against liver stages. "
10/17/2005 - "The risk of side effects from chemoprophylaxis needs to be balanced against the risk of infection, and there has been conducted only one prospective, double-blind study comparing the suspected side effects of mefloquine (Lariam), atovaquone/proguanil (Malarone), doxycycline and chloroquine/proguanil. "
04/01/1999 - "Adult volunteers received a three-day treatment course of Malarone to eliminate pre-existing parasitemia and were then immediately randomized to treatment with either one Malarone tablet daily (n = 136), or one placebo tablet daily (n = 138) for at least 10 weeks. "
09/01/2014 - "In all dogs except one treated with Malarone(®), parasitemia decreased, and anemia improved soon after initiation of treatment. "
11/01/2003 - "Plasmodium vivax malaria in spite of atovaquone/proguanil (malarone) prophylaxis."
10/01/2002 - "Atovaquone/proguanil (Malarone; GlaxoSmithKline) has been >95% effective in preventing Plasmodium falciparum malaria in lifelong residents of areas of holoendemicity, but data from persons without clinical immunity or who are at risk for Plasmodium vivax malaria have not been described. "
|7.||Antimalarials (Antimalarial Agents)